Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 19660659)

1.

Neuroprotection in acute brain injury: an up-to-date review.

Stocchetti N, Taccone FS, Citerio G, Pepe PE, Le Roux PD, Oddo M, Polderman KH, Stevens RD, Barsan W, Maas AI, Meyfroidt G, Bell MJ, Silbergleit R, Vespa PM, Faden AI, Helbok R, Tisherman S, Zanier ER, Valenzuela T, Wendon J, Menon DK, Vincent JL.

Crit Care. 2015 Apr 21;19(1):186. doi: 10.1186/s13054-015-0887-8.

2.

The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis.

Aksoy AN, Toker A, Celık M, Aksoy M, Halıcı Z, Aksoy H.

Indian J Pharmacol. 2014 Nov-Dec;46(6):622-6. doi: 10.4103/0253-7613.144922.

3.

Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

El-Etr M, Rame M, Boucher C, Ghoumari AM, Kumar N, Liere P, Pianos A, Schumacher M, Sitruk-Ware R.

Glia. 2015 Jan;63(1):104-17. doi: 10.1002/glia.22736. Epub 2014 Aug 4.

PMID:
25092805
4.

Water-soluble progesterone analogues are effective, injectable treatments in animal models of traumatic brain injury.

Guthrie DB, Stein DG, Liotta DC, Lockwood MA, Sayeed I, Atif F, Arrendale RF, Reddy GP, Evers TJ, Marengo JR, Howard RB, Culver DG, Natchus MG.

ACS Med Chem Lett. 2012 Mar 15;3(5):362-6. doi: 10.1021/ml200303r. eCollection 2012 May 10.

5.

Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor.

Frye CA, Koonce CJ, Walf AA.

Front Cell Neurosci. 2014 Apr 9;8:106. doi: 10.3389/fncel.2014.00106. eCollection 2014. Review.

6.

Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS.

Paris JJ, Fenwick J, McLaughlin JP.

Horm Behav. 2014 May;65(5):445-53. doi: 10.1016/j.yhbeh.2014.04.001. Epub 2014 Apr 12.

PMID:
24726788
7.

Differential effects of synthetic progestagens on neuron survival and estrogen neuroprotection in cultured neurons.

Jayaraman A, Pike CJ.

Mol Cell Endocrinol. 2014 Mar 25;384(1-2):52-60. doi: 10.1016/j.mce.2014.01.003. Epub 2014 Jan 11.

8.

Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury.

Santarsieri M, Niyonkuru C, McCullough EH, Dobos JA, Dixon CE, Berga SL, Wagner AK.

J Neurotrauma. 2014 Apr 15;31(8):699-712. doi: 10.1089/neu.2013.3177. Epub 2014 Feb 6.

9.

The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects.

Wei J, Xiao GM.

Acta Pharmacol Sin. 2013 Dec;34(12):1485-90. doi: 10.1038/aps.2013.160. Epub 2013 Nov 18. Review.

10.

Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Carver CM, Reddy DS.

Psychopharmacology (Berl). 2013 Nov;230(2):151-88. doi: 10.1007/s00213-013-3276-5. Epub 2013 Sep 27. Review. Erratum in: Psychopharmacology (Berl). 2013 Nov;230(2):189.

11.

Hormonal modulators of glial ABCA1 and apoE levels.

Fan J, Shimizu Y, Chan J, Wilkinson A, Ito A, Tontonoz P, Dullaghan E, Galea LA, Pfeifer T, Wellington CL.

J Lipid Res. 2013 Nov;54(11):3139-50. doi: 10.1194/jlr.M042473. Epub 2013 Sep 2.

12.

Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke.

Mdzinarishvili A, Sutariya V, Talasila PK, Geldenhuys WJ, Sadana P.

Drug Deliv Transl Res. 2013 Aug;3(4):309-17. doi: 10.1007/s13346-012-0117-8.

13.

Therapeutic effects of progesterone and its metabolites in traumatic brain injury may involve non-classical signaling mechanisms.

Cooke PS, Nanjappa MK, Yang Z, Wang KK.

Front Neurosci. 2013 Jun 13;7:108. doi: 10.3389/fnins.2013.00108. eCollection 2013.

14.

Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation.

D'Ambrosio R, Eastman CL, Fattore C, Perucca E.

Expert Rev Neurother. 2013 Jun;13(6):615-25. doi: 10.1586/ern.13.54. Review.

15.

Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection.

Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG.

Neuropharmacology. 2013 Apr;67:78-87. doi: 10.1016/j.neuropharm.2012.10.004. Epub 2012 Nov 12.

16.

Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone.

Yousuf S, Atif F, Sayeed I, Wang J, Stein DG.

Neuroscience. 2013 Jun 3;239:92-102. doi: 10.1016/j.neuroscience.2012.10.017. Epub 2012 Oct 16.

17.

A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat.

Peterson TC, Anderson GD, Kantor ED, Hoane MR.

J Neurotrauma. 2012 Dec 10;29(18):2823-30. doi: 10.1089/neu.2012.2471. Epub 2012 Nov 27.

18.

Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling.

Su C, Cunningham RL, Rybalchenko N, Singh M.

Endocrinology. 2012 Sep;153(9):4389-400. doi: 10.1210/en.2011-2177. Epub 2012 Jul 9.

19.

Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway.

Ishrat T, Sayeed I, Atif F, Hua F, Stein DG.

Neuroscience. 2012 May 17;210:442-50. doi: 10.1016/j.neuroscience.2012.03.008. Epub 2012 Mar 16.

20.

Perspectives on creating clinically relevant blast models for mild traumatic brain injury and post traumatic stress disorder symptoms.

Brenner LA, Bahraini N, Hernández TD.

Front Neurol. 2012 Mar 7;3:31. doi: 10.3389/fneur.2012.00031. eCollection 2012.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk